Adocia Arbitration Claim Against Eli Lilly Climbs To $1.8B
French biopharmaceutical company Adocia SA and Eli Lilly & Co. have stepped up their arbitral clash over the U.S. drugmaker's alleged misappropriation of confidential information, with Adocia increasing its damage demand...To view the full article, register now.
Already a subscriber? Click here to view full article